Clinical Profile of Patients with Scleritis in Bangladesh

Rahman, Zahedur; Jafarullah, Omar; Huq, Nayeemul; Hasan, Kamrul; Magesan, Kowsigan; Majumder, Parthopratim Dutta

doi:10.1080/09273948.2020.1716026

Cited by 8 publications

(6 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This frequency and subtypes were inconsistent with the studies in the literature. [ 14 15 16 ] The present study showed that 31% of scleritis from India had a systemic autoimmune disease. This finding is similar to previously published studies.…”

Section: Discussionmentioning

confidence: 58%

“…This is much less as compared to other studies. [ 15 23 ] Use of immunosuppressive agents might have helped in maintaining or improving the vision of the remaining 92% of the patient in our study. Two patients with necrotizing scleritis in our series developed globe perforation despite all treatment and including biologics given in one patient.…”

Section: Discussionmentioning

confidence: 94%

“…[ 5 9 ] Also, our finding confirms scleritis in India affects relatively younger population than other parts of the world. [ 11 12 13 14 15 16 17 18 19 20 ] Relatively younger age at presentation (37 ± 21 years) was noted in patients with posterior scleritis. Most importantly, four out of five patients with scleritis were <50 years.…”

Section: Discussionmentioning

confidence: 99%

“…In contrast, studies from Bangladesh and India revealed a significant association of mycobacterium tuberculosis in patients with nodular scleritis. [ 15 ] Considering the high prevalence of TB in India, it is recommended to screen all patients with scleritis for TB irrespective of clinical subtype. Mccluskey et al ,[ 23 ] in their study of 99 patients with posterior scleritis, found 29% of patients to have associated systemic disease and recommended aggressive treatment with immunosuppressive agents.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Clinical profile, treatment, and visual outcome of scleritis

Magesan

Patnaik

Majumder

et al. 2022

Oman Journal of Ophthalmology

View full text Add to dashboard Cite

PURPOSE: The purpose of this study was to analyze the clinical profile of patients with scleritis managed by a single ophthalmologist in a tertiary eye care center. METHODS: This was a retrospective analysis of 107 eyes of 96 patients with scleritis from January 2007 to December 2018. RESULTS: Female predominance (68%) with a relatively young-onset (46 ± 14 years) of scleritis was observed. Diffuse anterior scleritis (41%) was the most common subtype of scleritis, and the most common systemic association was rheumatoid arthritis (18%). Three-fourth of patients received immunosuppressive treatment (74%) along with corticosteroids. The mean follow-up period was 3 ± 2.5 (range: 0.6–10) years. Necrotizing scleritis was at a 3.5 times higher risk of developing ocular complications. Eighty percent of patients maintained the same vision. Recurrence of scleritis was noted in 25 eyes (23%). CONCLUSION: Diffuse scleritis is the most common scleritis in our population. Tuberculosis was commonly seen with diffuse scleritis. The likelihood of developing ocular complications (cataract and glaucoma) was higher in necrotizing scleritis, thus requiring periodic monitorization.

show abstract

Section: Discussionmentioning

confidence: 58%

Section: Discussionmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical profile, treatment, and visual outcome of scleritis

Magesan

Patnaik

Majumder

et al. 2022

Oman Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Posterior scleritis is a potentially sight-threatening, inflammatory process of the sclera that primarily involves the posterior segment of the eye [1]. It is an uncommon condition, affecting between 2.0 and 17.7% of all scleritis patients in retrospective epidemiological studies [2][3][4][5][6][7][8][9][10][11][12]. Posterior scleritis is reported to have a female preponderance in the majority of case series and can occur in all decades of life (Table 1) [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28].…”

Section: Introductionmentioning

confidence: 99%

Choroidal involvement in non-infectious posterior scleritis

Vermeirsch

Testi

Pavésio

2021

J Ophthal Inflamm Infect

View full text Add to dashboard Cite

Purpose To provide a comprehensive overview of choroidal involvement in non-infectious posterior scleritis; including different imaging modalities and their clinical usefulness. Methods Narrative review. Results Posterior scleritis is an uncommon yet potentially sight-threatening inflammation of the sclera. During the disease process, inflammation can spread to the adjacent choroid, causing different manifestations of choroidal involvement: (1) increased choroidal thickness, (2) choroidal vasculitis, (3) presentation as a choroidal or subretinal mass in nodular posterior scleritis, and (4) choroidal folds, choroidal effusion and exudative retinal detachment. Conclusions Clinical characteristics and multimodal imaging can aid in diagnosing and monitoring disease progression and response to treatment in non-infectious posterior scleritis with choroidal involvement.

show abstract

Granulomatosis/polyarteritis nodosa associated disorders

Chatziralli,

Pappelis

2024

Retinal and Choroidal Vascular Diseases of the Eye

View full text Add to dashboard Cite

Clinical Profile of Patients with Scleritis in Bangladesh

Cited by 8 publications

References 11 publications

Clinical profile, treatment, and visual outcome of scleritis

Clinical profile, treatment, and visual outcome of scleritis

Choroidal involvement in non-infectious posterior scleritis

Granulomatosis/polyarteritis nodosa associated disorders

Contact Info

Product

Resources

About